coronavirus
posit
sens
singlestrand
rna
virus
caus
import
diseas
human
anim
past
two
decad
least
three
novel
humanpathogen
coronavirus
cross
speci
barrier
caus
major
epidem
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
recent
emerg
sever
acut
respiratori
syndrom
coronaviru
emerg
late
novel
coronaviru
diseas
caus
dissemin
rapidli
around
globe
declar
pandem
march
confirm
case
report
world
health
organ
countri
territori
death
http
case
fatal
rate
estim
rang
resourcerich
set
epicentr
multipl
clinic
trial
evalu
known
novel
pharmacolog
agent
progress
innov
epidemiolog
model
mechanist
exploratori
studi
also
made
avail
time
write
effect
antivir
therapi
proven
clinic
benefit
widespread
global
transmiss
seem
inevit
countri
continu
implement
contain
strategi
advis
end
earli
test
diagnos
symptomat
asymptomat
infecti
individu
well
test
appar
recov
patient
may
continu
shed
viru
via
variou
rout
remain
essenti
outbreak
control
variou
group
made
publicli
avail
broadlyspecif
assay
target
pancoronavirus
variou
member
sarbecoviru
subgenu
modifi
assay
specif
oligonucleotid
probe
achiev
discrimin
http
identif
culprit
viral
speci
highlyspecif
assay
without
crossreact
closelyrel
virus
infect
human
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
need
studi
use
inhous
develop
program
golaymetamin
http
githubcomhkhccgolaymetamin
previous
obtain
genom
data
attempt
deduc
speciesspecif
target
conserv
among
global
detect
isol
identifi
target
primer
design
optim
highli
sensit
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
eventu
without
addit
use
fluoresc
report
probe
optim
assay
evalu
varieti
patient
specimen
final
potenti
applic
signific
newlydevelop
assay
well
known
limit
discuss
default
set
desktop
comput
equip
solidst
hard
disk
drive
kmer
size
number
thread
genom
subtract
run
complet
initi
genom
download
ncbi
default
paramet
bacteri
target
identif
uniqu
percentil
cutoff
centil
fail
report
target
length
nt
uniqu
percentil
score
cutoff
progress
relax
centil
consid
genom
length
bp
genom
uniquenessconserved
plot
shown
figur
total
four
uniqu
target
nt
length
tabl
report
potenti
target
short
exclud
program
minimum
median
maximum
uniqu
score
uscor
percentil
cutoff
minimum
median
maximum
conserved
score
cscore
due
overshoot
order
polynomi
smooth
function
four
report
target
tabl
subject
analysi
use
genscript
realtim
pcr
taqman
primer
probe
design
tool
http
wwwgenscriptcomtoolsrealtimepcrtaqmanprimerdesigntool
default
set
one
target
fulfil
primer
probe
design
criteria
target
tabl
initi
optim
hydrolysi
probebas
version
assay
show
reach
sensit
previous
publish
assay
data
shown
use
primer
develop
subsequ
probefre
realtim
rtpcr
assay
determin
analyt
sensit
assay
limit
detect
lod
evalu
use
viral
genom
rna
extract
cultur
isol
serial
dilut
rna
extract
viral
isol
prepar
test
triplic
two
independ
run
lod
assay
tabl
investig
whether
novel
assay
would
nonspecif
amplifi
humanpathogen
coronavirus
respiratori
virus
test
total
nucleic
acid
tna
extract
clinic
respiratori
specimen
tna
extract
cultur
isol
sarscov
merscov
respiratori
syncyti
viru
human
metapneumoviru
influenza
virus
influenza
b
viru
influenza
c
viru
parainfluenza
virus
type
rhinoviru
human
adenoviru
assay
show
cross
reactiv
virus
use
tna
extract
isol
differ
concentr
new
assay
perform
triplic
concentr
evalu
intra
interassay
variat
total
imprecis
cv
lowest
concentr
test
tabl
evalu
diagnost
perform
assay
clinic
specimen
posit
neg
confirm
case
defin
least
one
respiratori
specimen
posit
previous
establish
assay
use
neg
specimen
includ
extrapulmonari
eg
urin
rectal
swab
respiratori
tract
specimen
collect
later
phase
ill
viral
load
gradual
decreasedbecam
neg
twentythre
posit
includ
respiratori
specimen
stool
specimen
cp
valu
rang
neg
includ
four
respiratori
nonrespiratori
specimen
assay
melt
curv
specimen
show
uniqu
peak
melt
temperatur
around
result
two
assay
concord
addit
posit
result
detect
specimen
previous
test
neg
assay
earli
outbreak
viru
report
relat
sarscov
exact
genom
variat
viru
adequ
known
multipl
group
develop
publish
assay
base
conserv
region
could
potenti
detect
addit
coronavirus
see
also
http
advantag
tradit
approach
twofold
first
certain
method
detect
novel
member
clade
avoid
miss
case
clinic
second
posit
control
specimen
global
avail
begin
pandem
laboratori
speciesspecif
posit
control
could
use
exist
posit
control
sarscov
ensur
perform
assay
present
studi
demonstr
diagnost
perform
hydrolysi
probefre
assay
compar
previous
develop
assay
major
novelti
current
approach
applic
genom
subtract
deduc
previous
untarget
region
viral
genom
encod
subsequ
adopt
diagnost
assay
knowledg
assay
target
code
region
publish
previous
current
assay
highli
specif
without
crossreact
common
respiratori
virus
compar
assay
term
analyt
sensit
diagnost
sensit
specif
assay
comparison
assay
studi
reproduc
term
cp
valu
satisfactori
intra
interassay
coeffici
variat
valu
well
cutoff
specifi
literatur
furthermor
pcr
reaction
time
assay
within
hour
shorter
previous
develop
assay
distinct
advantag
clinic
laboratori
rapid
result
facilit
time
triag
suspect
case
guid
infect
control
patient
manag
term
function
signific
region
highlight
genom
subtract
corrobor
recent
model
studi
suggest
posit
select
region
within
protein
could
contribut
pathogen
viru
unfold
pandem
rapid
robust
sensit
diagnost
test
becam
prioriti
containmentbas
control
strategi
antibodybas
test
develop
even
made
commerci
avail
pointofcar
test
kit
lack
sensit
detect
earli
infect
host
success
mount
humor
respons
appli
certain
specimen
type
urin
antibodi
secret
glomerular
filtrat
unless
patient
develop
sever
renal
damag
use
determin
host
ceas
becom
infecti
nucleic
acid
amplificationbas
test
allow
exquisit
sensit
case
readili
adopt
laboratori
basic
molecular
facil
essenti
tool
clinic
manag
triag
patient
robust
design
optim
assay
requir
one
pair
primer
diagnos
infect
human
avoid
potenti
logist
reagent
manpow
constraint
perform
multipl
cascad
test
use
rel
costli
report
probe
develop
countri
medic
resourc
becom
critic
limit
believ
new
assay
may
adopt
allow
test
patient
shorter
time
valid
primer
set
publicli
avail
genom
supplementari
materi
found
propos
target
conserv
possibl
random
genet
drift
certain
subclon
viru
may
eventu
develop
mutat
escap
detect
rna
viru
typic
rel
high
mutat
rate
nucleotid
substitut
per
site
per
year
coronavirus
distinct
possibl
must
consid
howev
use
lessspecif
assay
pancoronaviru
primer
diagnost
laboratori
adopt
twotier
approach
first
attempt
confirm
infect
use
new
assay
subsequ
use
broadlyspecif
assay
clinic
suspici
case
rule
infect
final
golaymetamin
avail
free
opensourc
softwar
appli
effici
newli
deduc
mutant
sequenc
use
softwar
tool
degener
base
may
strateg
incorpor
assay
primer
broaden
specif
addit
target
may
iter
identifi
coronaviru
pangenom
analys
golaymetamin
softwar
initi
develop
school
biomed
scienc
chines
univers
hong
kong
inhous
softwar
design
speci
speciesgroup
specif
molecular
assay
mycobacterium
speci
depart
microbiolog
queen
mari
hospit
improv
upon
previous
publish
softwar
ssgenefind
golaymetamin
softwar
first
download
genom
target
nontarget
speci
ncbi
nucleotid
databas
gener
pool
nucleotid
kmer
k
default
forward
revers
direct
nontarget
genom
next
program
step
forward
strand
target
genom
primarytarget
assign
binari
uniqu
valu
either
kmer
uniqu
target
genom
kmer
found
nontarget
pool
pathogen
detect
assay
need
account
potenti
genom
variabl
target
pathogen
golaymetamin
softwar
step
target
genom
determin
kmer
also
present
intend
target
secondarytarget
secondarytargetlist
ad
valu
kmer
present
secondari
target
genom
kmer
absent
secondari
genom
conserved
valu
normal
maximum
valu
divid
absentpres
count
total
number
secondari
target
genom
plot
score
array
uniqu
conserved
valu
smooth
use
empir
optim
filter
window
size
polynomi
order
transform
continu
score
uscor
cscore
uscor
cutoff
calcul
accord
specifi
percentil
cutoff
default
studi
golaymetamin
execut
anaconda
python
environ
freeli
avail
http
wwwanacondacomdistribut
command
line
follow
python
gmmpi
primarytarget
secondarytargetlist
nontargetncbit
coronaviridaecompletecsv
exclusionstr
sever
acut
respiratori
syndrom
coronaviru
reportingcentil
longer
two
genom
sequenc
group
use
refer
genom
primarytarget
list
access
number
publicli
avail
genom
use
secondari
target
secondarytargetlist
access
number
refer
genom
manual
comment
avoid
doublecount
refer
genom
estim
conserved
nontarget
specifi
download
tabl
complet
coronavirida
genom
ncbi
genom
browser
http
wwwncbinlmnihgovgenomebrows
virus
pass
program
csv
file
nontargetncbit
coronaviridaecompletecsv
exclus
string
ad
exclud
entri
mark
genom
tabl
exclusionstr
sever
acut
respiratori
syndrom
coronaviru
genom
uscor
cutoff
empir
determin
default
set
percentil
could
yield
potenti
target
would
progress
relax
etc
genom
data
could
automat
download
golaymetamin
execut
genom
data
includ
softwar
distribut
respect
right
certain
sequenc
owner
list
access
number
coronaviru
genom
avail
supplementari
materi
complet
python
sourc
code
golaymetamin
softwar
freeli
avail
github
repositori
http
githubcomhkhccgolaymetamin
isol
nasopharyng
aspir
specimen
laboratoryconfirm
patient
hong
kong
previous
describ
viral
isol
stock
tissu
cultur
infect
dose
ml
prepar
use
cell
previous
describ
analyt
sensit
evalu
tna
extract
isol
use
analyt
specif
evalu
clinic
respiratori
specimen
cultur
isol
humanpathogen
coronavirus
respiratori
virus
use
assay
perform
evalu
archiv
clinic
specimen
respiratori
specimen
includ
nasopharyng
aspirateswab
throat
swab
endotrach
aspir
sputum
saliva
nonrespiratori
specimen
includ
plasma
urin
rectal
swabstool
patient
laboratoryconfirm
use
specimen
evalu
previous
use
establish
assay
studi
approv
institut
review
board
univers
hong
konghospit
author
uw
tna
extract
clinic
specimen
viral
cultur
isol
perform
use
nuclisen
easymag
extract
system
biomerieux
marcyl
franc
volum
specimen
use
extract
elut
volum
depend
specimen
type
amount
specimen
avail
previous
describ
realtim
rtpcr
assay
rna
detect
perform
use
quantinova
sybr
green
rtpcr
kit
qiagen
hilden
germani
lightcycl
ii
realtim
pcr
system
roch
basel
switzerland
reaction
mixtur
contain
quantinova
sybr
green
rtpcr
master
mix
qn
sybr
green
rtmix
forward
revers
primer
rnasefre
water
tna
templat
thermal
cycl
condit
min
min
follow
cycl
subject
melt
curv
analysi
min
follow
gradual
increas
temperatur
continu
record
fluoresc
use
golaymetamin
genom
subtract
region
success
identifi
use
coronaviru
genom
identifi
region
includ
conserv
sequenc
gene
absent
humanpathogen
coronavirus
previous
target
realtim
rtpcr
assay
highli
specif
sensit
assay
valid
use
multipl
viral
cultur
isol
clinic
specimen
newli
develop
assay
associ
genom
find
studi
contribut
control
understand
current
outbreak
